Back
Harmony Biosciences Holdings Vs. Arrowhead Pharmaceuticals Industry Stock Comparison
Buy
56
HRMY
Harmony Biosciences Holdings
Last Price:
33.88
Seasonality Move:
-2.13%
Sell
48
ARWR
Arrowhead Pharmaceuticals
Last Price:
28.17
Seasonality Move:
8.47%
Buy
56
Harmony Biosciences Holdings (HRMY)
is a Buy
Is Harmony Biosciences Holdings a Buy, Sell or Hold?
- The current Harmony Biosciences Holdings [HRMY] share price is $33.30. The Score for HRMY is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- HRMY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Arrowhead Pharmaceuticals (ARWR)
is a Sell
Is Arrowhead Pharmaceuticals a Buy, Sell or Hold?
- The current Arrowhead Pharmaceuticals [ARWR] share price is $28.93. The Score for ARWR is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- ARWR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HRMY Stock Price Chart
What is Harmony Biosciences Holdings's stock price today?
-
The Harmony Biosciences Holdings share price today is $33.30
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HRMY is experiencing slight selling pressure.
ARWR Stock Price Chart
What is Arrowhead Pharmaceuticals's stock price today?
-
The Arrowhead Pharmaceuticals share price today is $28.93
The current trend is moderately bullish and ARWR is experiencing selling pressure, which indicates risk of future bearish movement.
HRMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.72 | Buy |
| Relative Strength Index (14 RSI): | 56.34 | Buy |
| Chaikin Money Flow: | -12194 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.46 - 33.72) | Buy |
| Bollinger Bands (100): | (29.35 - 32.45) | Buy |
ARWR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.95 | Buy |
| Relative Strength Index (14 RSI): | 62.24 | Buy |
| Chaikin Money Flow: | -462455 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.45 - 28.55) | Buy |
| Bollinger Bands (100): | (23.35 - 28.81) | Buy |
HRMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.2 | Buy |
| 20-day SMA: | 32.6 | Buy |
| 50-day SMA: | 30.86 | Buy |
| 200-day SMA: | 30.2 | Buy |
| 8-day EMA: | 33.13 | Buy |
| 20-day EMA: | 32.55 | Buy |
| 50-day EMA: | 31.57 | Buy |
| 200-day EMA: | 31.81 | Buy |
ARWR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.61 | Buy |
| 20-day SMA: | 27.27 | Buy |
| 50-day SMA: | 25.79 | Buy |
| 200-day SMA: | 27.7 | Buy |
| 8-day EMA: | 28.5 | Buy |
| 20-day EMA: | 27.58 | Buy |
| 50-day EMA: | 26.52 | Buy |
| 200-day EMA: | 27.8 | Buy |
Harmony Biosciences Holdings Earnings Growth & HRMY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.04 per share, an increase this year of $0.01 per share, and an increase next year of $1.95 per share.
Arrowhead Pharmaceuticals Earnings Growth & ARWR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, an increase next quarter of $0.09 per share, a decrease this year of $1.71 per share, and an increase next year of $0.14 per share.
Harmony Biosciences Holdings Technical Analysis
| Jul 12 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 19 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Arrowhead Pharmaceuticals Technical Analysis
| Jul 12 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 19 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||